These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 692697)

  • 41. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF; Del Fiacco M; Iversen SD
    Adv Biochem Psychopharmacol; 1977; 16():589-95. PubMed ID: 560793
    [No Abstract]   [Full Text] [Related]  

  • 42. Response of dopamine neurons in substantia nigra to muscimol.
    MacNeil D; Gower M; Szymanska I
    Brain Res; 1978 Oct; 154(2):401-3. PubMed ID: 688000
    [No Abstract]   [Full Text] [Related]  

  • 43. The effects of intranigral injections of picrotoxin and carbachol in cats with a lesioned nigrostriatal pathway.
    Wolfarth S; Wand P; Sontag KH
    Neurosci Lett; 1979 Feb; 11(2):197-200. PubMed ID: 223087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Physiology and pharmacology of extrapyramidal tract].
    Yoshida M; Mizuno Y
    Nihon Rinsho; 1975 Oct; 33(10):2964-77. PubMed ID: 128646
    [No Abstract]   [Full Text] [Related]  

  • 45. Beyond the basal ganglia: cFOS expression in the cerebellum in response to acute and chronic dopaminergic alterations.
    Herrera-Meza G; Aguirre-Manzo L; Coria-Avila GA; Lopez-Meraz ML; Toledo-Cárdenas R; Manzo J; Garcia LI; Miquel M
    Neuroscience; 2014 May; 267():219-31. PubMed ID: 24631673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
    Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
    J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Morphofunctional features of the substantia nigra, its role in brain pathology and the action of pharmacologic substances].
    Arushanian EB
    Usp Fiziol Nauk; 1979; 10(2):45-72. PubMed ID: 38580
    [No Abstract]   [Full Text] [Related]  

  • 48. Evidence for a role of nigral gamma-aminobutyric acid and substance P in the haloperidol-induced activation of striatal tyrosine hydroxylase.
    Gale K; Costa E; Toffano G; Hong JS; Guidotti A
    J Pharmacol Exp Ther; 1978 Jul; 206(1):29-37. PubMed ID: 26799
    [No Abstract]   [Full Text] [Related]  

  • 49. GABAergic mechanisms in the substantia nigra.
    Waddington JL
    Nature; 1980 Feb; 283(5748):696-7. PubMed ID: 6101904
    [No Abstract]   [Full Text] [Related]  

  • 50. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of dorsal mesencephalic reticular formation and deep layers of superior colliculus as out-put stations for turning behaviour elicited from the substantia nigra pars reticulata.
    Imperato A; Porceddu ML; Morelli M; Faa G; Di Chiara G
    Brain Res; 1981 Jul; 216(2):437-43. PubMed ID: 7195766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 53. Rotatory behavior induced by glycine injected into the substantia nigra of the rat.
    Mendez JS; Finn BW; Dahl KE
    Exp Neurol; 1976 Jan; 50(1):174-9. PubMed ID: 1248538
    [No Abstract]   [Full Text] [Related]  

  • 54. Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro.
    Häusser MA; Yung WH
    J Physiol; 1994 Sep; 479 ( Pt 3)(Pt 3):401-22. PubMed ID: 7837097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The output neurones and the dopaminergic neurones of the substantia nigra receive a GABA-containing input from the globus pallidus in the rat.
    Smith Y; Bolam JP
    J Comp Neurol; 1990 Jun; 296(1):47-64. PubMed ID: 1694189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters.
    Hassler R
    Int J Neurol; 1979; 13(1-4):94-116. PubMed ID: 45452
    [No Abstract]   [Full Text] [Related]  

  • 57. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):271-84. PubMed ID: 2986775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Defense reaction mediated by NMDA mechanisms in the inferior colliculus is modulated by GABAergic nigro-collicular pathways.
    Nobre MJ; Lopes MG; Brandão ML
    Brain Res; 2004 Feb; 999(1):124-31. PubMed ID: 14746929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.